Publications by authors named "Victor H Jimenez-Zepeda"

46Publications

The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.

Authors:
Holly Lee Jason Tay Peter Duggan Sylvia McCulloch Paola Neri Nizar J Bahlis Victor H Jimenez-Zepeda

Eur J Haematol 2020 Nov 16. Epub 2020 Nov 16.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.

View Article and Find Full Text PDF
November 2020

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database.

Authors:
Hannah M Cherniawsky Vishal Kukreti Donna Reece Esther Masih-Khan Arleigh McCurdy Victor H Jimenez-Zepeda Michael Sebag Kevin Song Darrell White Julie Stakiw Richard LeBlanc Anthony Reiman Muhammad Aslam Martha Louzada Rami Kotb Engin Gul Eshetu Atenafu Christopher P Venner

Haematologica 2020 Oct 13;Online ahead of print. Epub 2020 Oct 13.

Cross Cancer Institute, University of Alberta, Edmonton, Alberta.

View Article and Find Full Text PDF
October 2020

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes.

Authors:
Carolina Diaz-Pallares Holly Lee Joanne Luider Peter Duggan Paola Neri Jason Tay Sylvia MacCulloch Nizar J Bahlis Victor H Jimenez-Zepeda

Clin Lymphoma Myeloma Leuk 2020 06 7;20(6):394-399. Epub 2019 Nov 7.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada. Electronic address:

View Article and Find Full Text PDF
June 2020

The Prognostic Role of Lactate Dehydrogenase at First Relapse of Multiple Myeloma.

Authors:
Holly Lee Victor H Jimenez-Zepeda

Acta Haematol 2020 26;143(6):516-517. Epub 2020 Feb 26.

Division of Hematology, Department of Medicine, Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada,

View Article and Find Full Text PDF
January 2021

Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera.

Authors:
Holly Lee Sylvia McCulloch Etienne Mahe Mona Shafey Fariborz Rashid-Kolvear Faisal Khan Dwip Prajapati Paola Neri Peter Duggan Jason Tay Nizar Bahlis Victor H Jimenez-Zepeda

Br J Haematol 2020 05 20;189(3):e114-e118. Epub 2020 Feb 20.

Tom Baker Cancer Center, Department of Medical Oncology and Hematology, University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
May 2020

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center.

Authors:
Patrick Yau Victor H Jimenez-Zepeda Kyla Bailey Peter Duggan Jason Tay Nizar J Bahlis Paola Neri Sylvia McCulloch

Leuk Lymphoma 2019 12 13;60(13):3199-3203. Epub 2019 Jun 13.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.

View Article and Find Full Text PDF
December 2019

Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin.

Authors:
Rosy Dabas Kareem Jamani Shahbal B Kangarloo Poonam Dharmani-Khan Tyler S Williamson Samar Ousia Caylib Durand Don Morris Douglas Mahoney Lynn Savoie Ahsan Chaudhry Victor H Jimenez-Zepeda Faisal M Khan Andrew Daly Jan Storek

Blood Adv 2019 05;3(9):1394-1405

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
May 2019

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.

Authors:
Chandini M Thirukkumaran Zhong Qiao Shi Gerard J Nuovo Joanne Luider Karen A Kopciuk Yuan Dong Ahmed A Mostafa Satbir Thakur Kathy Gratton Ailian Yang Alex C Chin Matt C Coffey Victor H Jimenez-Zepeda Douglas Stewart Marta Chesi P Leif Bergsagel Don Morris

Blood Adv 2019 03;3(5):797-812

Division of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; and.

View Article and Find Full Text PDF
March 2019

Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.

Authors:
Holly Lee Peter Duggan Paola Neri Jason Tay Victor H Jimenez-Zepeda

Mediterr J Hematol Infect Dis 2019 1;11(1):e2019007. Epub 2019 Jan 1.

Tom Baker Cancer Center, Department of Medical Oncology and Hematology, Calgary, AB, Canada.

View Article and Find Full Text PDF
January 2019

Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder.

Authors:
Amit Kalra Cameron Roessner Jennifer Jupp Tyler Williamson Raymond Tellier Ahsan Chaudhry Faisal Khan Minakshi Taparia Victor H Jimenez-Zepeda Douglas A Stewart Andrew Daly Jan Storek

Cytotherapy 2018 05 23;20(5):706-714. Epub 2018 Mar 23.

University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
May 2018

Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institution.

Authors:
Victor H Jimenez-Zepeda Peter Duggan Paola Neri Ahsan Chaudhry Jason Tay Nizar Bahlis

Leuk Lymphoma 2018 08 21;59(8):1920-1926. Epub 2017 Nov 21.

a Department of Medical Oncology and Hematology , Tom Baker Cancer Center , Calgary , Canada.

View Article and Find Full Text PDF
August 2018

Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience.

Authors:
Holly Lee Peter Duggan Ahsan Chaudhry Paola Neri Jason Tay Fariborz Rashid-Kolvear Nizar J Bahlis Victor H Jimenez-Zepeda

Clin Lymphoma Myeloma Leuk 2018 01 1;18(1):e69-e75. Epub 2017 Nov 1.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada. Electronic address:

View Article and Find Full Text PDF
January 2018

Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.

Authors:
Amit Kalra Cameron Roessner Jennifer Jupp Tyler Williamson Raymond Tellier Ahsan Chaudhry Faisal Khan Minakshi Taparia Victor H Jimenez-Zepeda Douglas A Stewart Andrew Daly Jan Storek

Clin Transplant 2018 01 1;32(1). Epub 2017 Dec 1.

University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
January 2018

Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis.

Authors:
Hina Qamar Adrienne Lee Karen Valentine Leslie Skeith Victor H Jimenez-Zepeda

Mediterr J Hematol Infect Dis 2017 1;9(1):e2017034. Epub 2017 May 1.

Tom Baker Cancer Center, Department of Medical Oncology and Hematology, Calgary, AB, Canada.

View Article and Find Full Text PDF
May 2017

Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.

Authors:
Marina Ramirez-Alvarado David R Barnidge David L Murray Angela Dispenzieri Marta Marin-Argany Christopher J Dick Shawna A Cooper Samih H Nasr Christopher J Ward Surendra Dasari Víctor H Jiménez-Zepeda Nelson Leung

Am J Hematol 2017 Jun 4;92(6):536-541. Epub 2017 May 4.

Division of Hematology, Mayo Clinic, MN, 55905, USA.

View Article and Find Full Text PDF
June 2017

Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma.

Authors:
Victor H Jimenez-Zepeda Peter Duggan Paola Neri Jason Tay Nizar J Bahlis

Ann Hematol 2017 Mar 10;96(3):431-439. Epub 2017 Jan 10.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, 1331 29th St, NW, Calgary, AB, T2N 4N2, Canada.

View Article and Find Full Text PDF
March 2017

Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.

Authors:
Kareem Jamani Judy MacDonald Martin Lavoie Tyler S Williamson Christopher B Brown Ahsan Chaudhry Victor H Jimenez-Zepeda Peter Duggan Jason Tay Douglas Stewart Andrew Daly Jan Storek

Blood Adv 2016 Dec 30;1(2):152-159. Epub 2016 Nov 30.

Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada.

View Article and Find Full Text PDF
December 2016

Revised International Staging System Applied to Real World Multiple Myeloma Patients.

Authors:
Victor H Jimenez-Zepeda Peter Duggan Paola Neri Fariborz Rashid-Kolvear Jason Tay Nizar J Bahlis

Clin Lymphoma Myeloma Leuk 2016 09 8;16(9):511-518. Epub 2016 Jun 8.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada. Electronic address:

View Article and Find Full Text PDF
September 2016

Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience.

Authors:
Victor H Jimenez-Zepeda Peter Duggan Paola Neri Nizar J Bahlis

Clin Lymphoma Myeloma Leuk 2016 Jun 29;16(6):e79-84. Epub 2016 Mar 29.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
June 2016

Bortezomib and melphalan conditioning increases the rate of complete response and MRD negativity for patients with multiple myeloma undergoing single autologous stem cell transplant.

Authors:
Victor H Jimenez-Zepeda Peter Duggan Paola Neri Ahsan Chaudhry Karen Murray Marcia Culham Joanne Luider Thomas Fourie Fariborz Rashid-Kolvear Nizar J Bahlis

Leuk Lymphoma 2016 8;57(4):973-6. Epub 2015 Oct 8.

a Tom Baker Cancer Center , Department of Medical Oncology and Hematology , Calgary , AB , Canada .

View Article and Find Full Text PDF
December 2016